DBV Technologies (DBVT) FCF Margin (2020 - 2026)
DBV Technologies (DBVT) posted quarterly FCF Margin of 7571.43% for Q2 2026, down 531143.0% year-on-year from N/an in Q2 2025, and down 37.66% on a QoQ basis from 5500.0% in Q1 2026.
DBV Technologies (DBVT) FCF Margin (2020 - 2026) Analysis & Trends
DBV Technologies (DBVT) has reported FCF Margin for 7 consecutive years, with 7571.43% the latest figure, recorded in Q2 2026.
- Quarterly FCF Margin fell 531143.0% year-over-year to 7571.43% in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 3399.34% (down 114654.0% YoY) and the FY2025 annual result came in at 2159.56%, up 38358.0% from the prior year.
- FCF Margin fell to 7571.43% in Q2 2026 per DBVT's latest filing, from 5500.0% in the prior quarter.
- Over the last five years, FCF Margin for DBVT reached as high as 1832.59% in Q4 2022 and fell as low as 7571.43% in Q2 2026.
- A 5-year average of 2077.03% and a median of 1652.91% in 2024 frame the typical range for FCF Margin.
- Annual changes were most pronounced in 2022 — FCF Margin soared 250449 bps — and 2026, when it sank 531143 bps.
- Year by year, FCF Margin stood at 1832.59% in 2022, then plunged by 109 bps to 158.17% in 2023, then plunged by 1269 bps to 2165.54% in 2024, then tumbled by 154 bps to 5511.01% in 2025, then tumbled by 37 bps to 7571.43% in 2026.
- According to Business Quant data, FCF Margin over the past three periods registered 7571.43%, 5500.0%, and 5511.01% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 10.45% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 43.35% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 23.53% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | DBV Technologies | 267.50 Mn | 92.60 Mn | - | -7,571.43% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -7,571.43% |
| Mar 31, 2026 | -5,500.00% |
| Dec 31, 2025 | -5,511.01% |
| Sep 30, 2025 | -1,174.01% |
| Jun 30, 2025 | -2,260.00% |
| Mar 31, 2025 | -2,462.50% |
| Dec 31, 2024 | -2,165.54% |
| Sep 30, 2024 | -2,131.81% |
| Jun 30, 2024 | -3,083.98% |
| Mar 31, 2024 | -2,560.55% |
| Dec 31, 2023 | -158.17% |
| Sep 30, 2023 | -827.28% |
| Jun 30, 2023 | -1,123.99% |
| Mar 31, 2023 | -954.97% |
| Dec 31, 2022 | 1,832.59% |
| Sep 30, 2022 | -984.62% |
| Jun 30, 2022 | -685.94% |
| Mar 31, 2022 | -63.39% |
| Dec 31, 2021 | -671.90% |
| Sep 30, 2021 | -1,733.64% |